Found: 8
Select item for more details and to access through your institution.
CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1240, doi. 10.1002/ajh.27316
- By:
- Publication type:
- Article
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E105, doi. 10.1002/ajh.24715
- By:
- Publication type:
- Article
Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoeitic stem cell transplantation.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1028162
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 34, doi. 10.1016/j.clml.2021.07.027
- By:
- Publication type:
- Article
Apport du panel multiparamétrique CD3 CD4 CD8 CD7 CD26 CD158k dans la détection et le suivi par cytométrie en flux des cellules de Sézary.
- Published in:
- Annales de Biologie Clinique, 2021, v. 79, n. 3, p. 233, doi. 10.1684/abc.2021.1651
- By:
- Publication type:
- Article
Age‐related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 1, p. 122, doi. 10.1111/bjh.18822
- By:
- Publication type:
- Article
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6574, doi. 10.3390/jcm11216574
- By:
- Publication type:
- Article
Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0469-0
- By:
- Publication type:
- Article